糖尿病视网膜病变药物治疗进展  

Progress on the pharmacotherapy of diabetic retinopathy.

作　　者：韦艳[1] 任巧霞[1] 吴冰[1] 

机构地区：[1]兰州军区兰州总医院眼科中心,甘肃兰州730050

出　　处：《海南医学》2013年第11期1657-1659,共3页Hainan Medical Journal

摘　　要：激光光凝术目前仍是治疗糖尿病视网膜病变的金标准,当前药物治疗作为激光治疗的辅助治疗手段,可有效预防糖尿病视网膜病变所致的视力缺损。本文就糖尿病视网膜病变药物治疗新进展进行综述。Laser photocoagulation is still the gold standard therapy of diabetic retinopathy. Present pharmacotherapy, as an adjunct to laser photocoagulation, serves as a useful tool in the prevention of vision loss from diabetic retinopathy and related disorders. This review summarizes the up-to-date developments in the pharmacotherapy of diabetic retinopathy.

关 键 词：糖尿病视网膜病变 激光光凝术 药物治疗 

分 类 号：R587.2[医药卫生—内分泌]